WAVE WORKSHOP · DAILY 4H

Your trading brief

Edition: 15 October 2026
Prices: 14 October 2026 US close

Today’s key events · UK time

07:00 BST
TSMC earnings conference

Taiwan Semiconductor Manufacturing Company Limited (TSM.US, Technology): scheduled 14:00 Taiwan / 02:00 ET / 07:00 UK earnings conference. This row records the conference; the separate results-release timestamp and actual results are not verified at this cutoff. AI demand, margins and investment plans may inform semiconductor holdings.

13:30 BST
US producer inflation

September PPI scheduled 08:30 ET / 13:30 UK. Assess the released change and consensus surprise separately; no outcome or market reaction assumed.

13:30 BST
US retail sales

September advance retail sales scheduled 08:30 ET / 13:30 UK; nominal spending is not an inflation-adjusted consumption measure. Await the release and audited price reaction.

13:30 BST
US jobless claims

Weekly initial claims scheduled 08:30 ET / 13:30 UK; a single weekly reading does not establish the employment trend.

13:30 BST
Regional factory surveys

October Empire State and Philadelphia Fed manufacturing surveys scheduled 08:30 ET / 13:30 UK. Regional surveys are partial growth and price evidence, not national output.

13:30 BST
Schwab business update

The Charles Schwab Corporation (SCHW.US, Financial Services): public update 08:30–09:30 ET / 13:30–14:30 UK. Quarterly report is dated today but its exact release time is unspecified in the checked issuer source; this time marks the update.

15:00 BST
PNC earnings call

The PNC Financial Services Group, Inc. (PNC.US, Financial Services): separate conference call 10:00 ET / 15:00 UK. Exact results-release time was not verified; do not label this the release.

15:00 BST
US business inventories

August business inventories scheduled 10:00 ET / 15:00 UK. Lagged inventory data require demand context.

21:00 BST
Interactive Brokers results

Interactive Brokers Group, Inc. (IBKR.US, Financial Services): release scheduled approximately16:00ET /21:00UK, with a separate16:30ET /21:30UK call. This is scheduled financial reporting; no actual result or surprise is assumed.

22:00 BST
J.B. Hunt earnings call

J.B. Hunt Transport Services, Inc. (JBHT.US, Industrials): earnings expected at the US market close; separate call16:00CDT /17:00ET /22:00UK. This row marks the call, not an exact results-release timestamp.

22:00 BST
Alcoa earnings call

Alcoa Corporation (AA.US, Basic Materials): Q3 presentation and call17:00ET /22:00UK. Results are scheduled after the NYSE close; exact release clock time unverified.

No FOMC rate decision today; next meeting October27–28. Warsh discussion Thursday23:30ET falls on Friday October16 at04:30UK. Bowman October14 22:55ET discussion fell on October15 at03:55UK, before this edition; no speech-content outcome is inferred. Selected scheduled highlights for 2026-10-15; check linked calendars for revisions.

Market regime · Risk-on bias

Prior US session: 2026-10-14 · Equity trend overlay · Limited macro coverage.

Favour qualified long setups; assess shorts on their individual merits. Existing trigger, sizing and short-exposure limits apply.

Breadth, volatility, credit, rates and dollar confirmation are not yet included. This is an index-trend bias, not a confirmed full macro regime or an automatic trading signal.

Method and coverage

Both SPY and QQQ above their daily SMA50 and daily SMA20 rising over five sessions: risk-on bias; both below SMA50 and SMA20 falling: risk-off bias; otherwise mixed. Missing essential history: unavailable. Provisional uncalibrated rules. Daily series are split/dividend adjusted; separate from portfolio price-return marks.

Sector performance

Sorted by the latest completed session. Both returns sit side by side; the smaller figures show the difference from SPY. SPY plus eleven sectors: 12/12 current.

SPY · S&P 500Comparison · outside sector ranks
-1.08%Last session
-0.98%Five sessions

Daily: 2026-10-13 → 2026-10-14 close. Five trading sessions (roughly one week): 2026-10-07 → 2026-10-14 close.

Sector / ETFLast session5 sessions
1. Health care (XLV)Health Care Select Sector SPDR Fund+2.53%+3.62 pp vs SPY+3.05%+4.03 pp vs SPY
2. Consumer staples (XLP)Consumer Staples Select Sector SPDR Fund+2.22%+3.30 pp vs SPY+5.34%+6.32 pp vs SPY
3. Energy (XLE)Energy Select Sector SPDR Fund+0.64%+1.72 pp vs SPY+6.74%+7.72 pp vs SPY
4. Materials (XLB)Materials Select Sector SPDR Fund-0.10%+0.98 pp vs SPY+1.41%+2.39 pp vs SPY
5. Utilities (XLU)Utilities Select Sector SPDR Fund-0.36%+0.72 pp vs SPY+1.39%+2.37 pp vs SPY
6. Financials (XLF)Financial Select Sector SPDR Fund-0.55%+0.53 pp vs SPY+1.43%+2.41 pp vs SPY
7. Consumer discretionary (XLY)Consumer Discretionary Select Sector SPDR Fund-0.77%+0.32 pp vs SPY+0.13%+1.11 pp vs SPY
8. Real estate (XLRE)Real Estate Select Sector SPDR Fund-0.81%+0.27 pp vs SPY+2.27%+3.25 pp vs SPY
9. Industrials (XLI)Industrial Select Sector SPDR Fund-0.97%+0.11 pp vs SPY-0.48%+0.50 pp vs SPY
10. Communication services (XLC)Communication Services Select Sector SPDR Fund-1.30%-0.22 pp vs SPY-0.40%+0.58 pp vs SPY
11. Technology (XLK)Technology Select Sector SPDR Fund-2.98%-1.90 pp vs SPY-5.44%-4.46 pp vs SPY

Five-session leader: Energy (XLE) +6.74%; weakest: Technology (XLK) -5.44%.

Close-to-close changes on matching saved EODHD split/dividend-adjusted daily prices, not official index total returns. Positive returns need not beat SPY. Performance ranks are context, not trade signals.

Technical setups

No interesting ETF technical setup found under the existing completed-4H qualification rules.

Dated SPY + eleven-sector evidence audit

Daily stock ranking

301/301 names verified through 2026-10-14. All six-signal leaders shown. Ranking uses relative strength versus SPY, EMA trend, positive MACD alignment, proximity to the 52-week high, combined RS/MACD and relative volume. This ranking does not establish a 4H entry. Fewer than 252 daily bars makes the 52-week-high signal unavailable/false; HONA and SPCX have limited daily history, not full method qualification.

CompanySignals / 6CloseRS60 vs SPYRelative volumeHistory / research status
FAST — Fastenal Company · Industrials6$52.0013.1%3.57×276 bars; Unexecuted research; Assessed: no qualifying current 4H setup

Local recovery from authenticated EODHD daily screening sources, same400-calendar-day input window and six-signal arithmetic as private-assets/daily-screener.html; no owner saved-ranking endpoint access attempted in this run. Recovery uses authenticated daily source snapshots and exact browser arithmetic checks; this is not retrieval or modification of the owner’s saved-ranking endpoint. Same vendor provenance; no second-provider price verification. All 301 names in the dated audit.

Six-signal stocks · Alex’s technical review

The daily ranking identifies research candidates. Each is assessed separately on completed 4H evidence; six daily signals do not establish a trade.

Fastenal Company (FAST)Industrials · Industrial Distribution

No qualifying current 4H setup

Prices through 2026-10-14 20:00:00 UTC. EODHD · 2998 completed 4H bars. Reviewed 2026-10-15T07:46:43.722Z; later prices are excluded.

Weekly / daily context: Last completed week (9 October) closed at $50.75, above its 10-week $50.38 and 40-week $46.50 averages. The adjusted daily close was $52.00, above rising 50/100/200-day averages. The current partial week is excluded; daily prices use their separately saved adjusted basis.

Channels and levels: The last 30 completed 4H high/low regressions are mixed and expanding, not a confirmed parallel channel. The observed range is $47.30–$52.42; the latest completed bar closed at $52.01 after trading down to $51.40.

Classical pattern: No current classical pattern was detected on the audited 4H snapshot. The separate daily triangle has only 0.92:1 measured reward/risk at its daily close; it does not establish a qualifying 4H entry.

Averages and momentum: 4H price is above rising SMA50 $50.18, SMA100 $50.39 and SMA200 $48.26. RSI is 63.28; MACD 0.4383 is above its 0.3069 signal (histogram +0.1314), with a bullish crossover five completed bars ago. No confirmed recent RSI/MACD divergence is present.

Competing case and monitoring: Bullish momentum supports continuation, but the unusually wide latest-session range can reverse. A completed close above the observed $52.42 range high would support follow-through; a close below the latest-bar $51.40 low would weaken that near-term reading. $47.30 is broad support, not a recommended stop. These are monitoring conditions, not a qualified entry, target or portfolio decision.

Elliott / Fibonacci: No supported Elliott count is supplied by this snapshot, so no wave degree or Fibonacci target is asserted. Conclusion: six daily signals merit this review, but there is no qualifying current 4H setup.

47495153RSI (14)7030MACD (12, 26, 9)0MACDSignalTTM squeeze / momentum0Amber dots: compression · grey: off · last 20 bars28 Aug14 Oct
4H completed candles · EODHD · RSI 14 · MACD 12/26/9 · TTM 20. Dashed purple lines join matching price/indicator pivots; reference levels are not orders

Dated technical evidence and limitations. Monitoring levels are conditional observations, not an automatic entry or model selection.

Today’s technical setups

5 price setups to examine, with the case for each and the risks beside it. Setup validity and model-portfolio allocation are separate decisions. Maya’s news and social-attention sections follow the charts.

Alex’s setups — the case and the caution

GILD Gilead Sciences Inc ↑Healthcare · Drug Manufacturers - General

TECHNICAL SETUP

Inverse head & shoulders · Bullish price pattern · Last close $153.55

Why bullish: The inverse head & shoulders has broken upward on a completed candle, favouring a possible continuation higher. The closing price is above its 50-bar average ($148.45) and above its 200-bar average ($137.01).

What could go wrong: Breakout volume supports the move. A move below $147.26 would undermine this pattern.

TTM Squeeze · 4H: Squeeze is off; its last observed release was 17 completed bars ago. Momentum is bullish and rising (4.31). Momentum direction agrees with this setup. No fresh directional squeeze trigger.

141148156164Target $162.02Breakout $152.16Stop $147.26RSI (14)7030MACD (12, 26, 9)0MACDSignalTTM squeeze / momentum0Amber dots: compression · grey: off · last 20 bars28 Aug14 Oct
4H completed candles · EODHD · RSI 14 · MACD 12/26/9 · TTM 20. Dashed purple lines join matching price/indicator pivots; reference levels are not orders
Open interactive chart →
Breakout reference$152.16Stop reference$147.26Target reference$162.02Reward / risk at close1.3 : 1

Sam: technical risk review. Setup remains on watch; current reward/risk is below Sam’s 1.5:1 portfolio entry preference — consider a better entry. See the dated company coverage and Sam’s decisions below for event checks and sizing; executable spreads are not verified.

Wave alternatives, company news & analyst evidence

Elliott-wave scenario · 4H

Leading count · 4H0123? · $154.8610-06 → 10-14 · Close $153.55
Grey: price closes. Colour: proposed count. Dashed: target scenario; timing is illustrative. Provisional.

Leading reading: Bullish contracting diagonal · developing · Wave 3. Potential Wave 3 target $154.86 (0.8% from the reported close). Wave trigger $152.26; count invalidation $142.60. Provisional: parent-degree/subdivision or other method checks remain unresolved; not a confirmed wave count.

Alternative count · 4H0123? · $162.8910-06 → 10-14 · Close $153.55
Grey: price closes. Colour: proposed count. Dashed: target scenario; timing is illustrative. Provisional.

Competing reading: Bullish expanding diagonal · developing · Wave 3. Potential Wave 3 target $162.89 (6.1% from the reported close). Wave trigger $152.26; count invalidation $142.60. Provisional: parent-degree/subdivision or other method checks remain unresolved; not a confirmed wave count.

Wave projections and classical-pattern targets are separate scenarios, not interchangeable take-profit orders. The interactive chart may use newer candles or different session grouping.

Maya · Company news

Recent company news. Date-only recent news: Vir Biotechnology announced a three-candidate solid-tumor T-cell engager collaboration giving Gilead exclusive development/commercialization rights. Upfront consideration totals$90m ($65m cash/$25m equity), plus conditional milestones. Interpretation: pipeline breadth with development risk, not approved products or guaranteed earnings. First publication clock time unverified.

Source dated 2026-10-14 Publication time unverified; not classified as overnight.

Checked 2026-10-15T05:34:44.460Z.

Maya · Wall Street view

Reported rating changes: last 7 days — 0 upgrades / 0 downgrades; last 30 days — 0 upgrades / 0 downgrades. Partial coverage: counts are only the events found, not market-wide totals.

Covered analyst consensus: 19 Buy / 4 Hold / 0 Sell (23 ratings), as of 2026-10-15. Displayed public covered-analyst snapshot checked October15; Strong Buy grouped with Buy. Partial, cache-dependent census. Source.

  • 2026-10-08 · RBC Capital: target raise · target USD 123 → 126. Source
  • 2026-10-08 · Cantor Fitzgerald: reiteration. Source
  • 2026-10-07 · Truist Securities: target raise · target USD 150 → 158. Source

Target changes in 30 days: 3 raises / 1 cuts (separate from rating changes). Selected visible attributed actions from rolling30-day window; bounded public table and cache coverage are incomplete. Zero counts mean none found here, not market-wide zeros. Targets are opinions, not measured returns. Checked 2026-10-15T05:34:44.460Z. Analyst opinion is context, not a trade trigger.

MET MetLife Inc ↑Financial Services · Insurance - Life

TECHNICAL SETUP

Inverse head & shoulders · Bullish price pattern · Last close $99.72

Why bullish: The inverse head & shoulders has broken upward on a completed candle, favouring a possible continuation higher. The closing price is above its 50-bar average ($97.08) and above its 200-bar average ($92.64).

What could go wrong: Breakout volume is still unconfirmed. A move below $95.42 would undermine this pattern.

TTM Squeeze · 4H: Squeeze is off; its last observed release was 20 completed bars ago. Momentum is bullish and falling (3.95). Momentum direction agrees with this setup. No fresh directional squeeze trigger.

9196102107Target $106.00Breakout $99.44Stop $95.42RSI (14)7030MACD (12, 26, 9)0MACDSignalTTM squeeze / momentum0Amber dots: compression · grey: off · last 20 bars28 Aug14 Oct
4H completed candles · EODHD · RSI 14 · MACD 12/26/9 · TTM 20. Dashed purple lines join matching price/indicator pivots; reference levels are not orders
Open interactive chart →
Breakout reference$99.44Stop reference$95.42Target reference$106.00Reward / risk at close1.5 : 1

Sam: technical risk review. Setup remains on watch; current reward/risk is below Sam’s 1.5:1 portfolio entry preference — consider a better entry. Breakout volume unconfirmed. See the dated company coverage and Sam’s decisions below for event checks and sizing; executable spreads are not verified.

Wave alternatives, company news & analyst evidence

Elliott-wave scenario · 4H

Leading count · 4H0ABC10-01 → 10-14 · Close $99.72
Grey: price closes. Colour: proposed count. Provisional.

Leading reading: Bullish ABC zigzag. No usable projected target supplied for this reading. Provisional: parent-degree/subdivision or other method checks remain unresolved; not a confirmed wave count.

Alternative count · 4H012310-01 → 10-14 · Close $99.72
Grey: price closes. Colour: proposed count. Provisional.

Competing reading: Bullish contracting diagonal · developing. No usable projected target supplied for this reading. Provisional: parent-degree/subdivision or other method checks remain unresolved; not a confirmed wave count.

Wave projections and classical-pattern targets are separate scenarios, not interchangeable take-profit orders. The interactive chart may use newer candles or different session grouping.

Maya · Company news

Scheduled event. Scheduled earnings: MetLife will release Q3 results November4 after the US close; separate call November5 at09:00–10:00ET. This October7 calendar announcement is older background, not fresh operating news. Current overnight company-news coverage remains incomplete.

Source dated 2026-10-07

No fresh material item identified in the checked coverage. No newer material item identified in this bounded accessible issuer/archive/search review; dynamic archive coverage and exact earnings timing remain incomplete. This is not proof of no news. Newsroom checked.

Checked 2026-10-15T05:34:44.460Z.

Maya · Wall Street view

Reported rating changes: last 7 days — 0 upgrades / 0 downgrades; last 30 days — 1 upgrades / 0 downgrades. Partial coverage: counts are only the events found, not market-wide totals.

Covered analyst consensus: 14 Buy / 2 Hold / 0 Sell (16 ratings), as of 2026-10-15. Displayed public covered-analyst snapshot checked October15; Strong Buy grouped with Buy. Partial, cache-dependent census. Source.

  • 2026-10-12 · Wells Fargo: target raise · target USD 109 → 110. Source
  • 2026-10-07 · Mizuho: target cut · target USD 112 → 109. Source
  • 2026-10-07 · Barclays: target raise · target USD 97 → 111. Source

Target changes in 30 days: 4 raises / 1 cuts (separate from rating changes). Selected visible attributed actions from rolling30-day window; bounded public table and cache coverage are incomplete. Zero counts mean none found here, not market-wide zeros. Targets are opinions, not measured returns. Checked 2026-10-15T05:34:44.460Z. Analyst opinion is context, not a trade trigger.

MO Altria Group ↑Consumer Defensive · Tobacco

TECHNICAL SETUP

Bull flag · Bullish price pattern · Last close $73.15

Why bullish: Price rose, paused in a short counter-trend channel, then broke above that channel. This supports a possible continuation higher. The closing price is above its 50-bar average ($69.34) and above its 200-bar average ($68.99).

What could go wrong: Breakout volume supports the move. A move below $71.14 would undermine this pattern.

TTM Squeeze · 4H: Squeeze is off; its last observed release was 19 completed bars ago. Momentum is bullish and rising (3.91). Momentum direction agrees with this setup. No fresh directional squeeze trigger.

65697478Target $77.02Breakout $72.44Stop $71.14RSI (14)7030MACD (12, 26, 9)0MACDSignalTTM squeeze / momentum0Amber dots: compression · grey: off · last 20 bars28 Aug14 Oct
4H completed candles · EODHD · RSI 14 · MACD 12/26/9 · TTM 20. Dashed purple lines join matching price/indicator pivots; reference levels are not orders
Open interactive chart →
Breakout reference$72.44Stop reference$71.14Target reference$77.02Reward / risk at close1.9 : 1

Sam: technical risk review. See the dated company coverage and Sam’s decisions below for event checks and sizing; executable spreads are not verified.

Wave alternatives, company news & analyst evidence

Elliott-wave scenario · 4H

Leading count · 4H0ABC09-01 → 10-14 · Close $73.15
Grey: price closes. Colour: proposed count. Provisional.

Leading reading: Bearish expanded-flat. No usable projected target supplied for this reading. Provisional: parent-degree/subdivision or other method checks remain unresolved; not a confirmed wave count.

Wave projections and classical-pattern targets are separate scenarios, not interchangeable take-profit orders. The interactive chart may use newer candles or different session grouping.

Maya · Company news

Recent company news. Date-only recent news: Altria’s visible latest release concerns the on!vitational golf promotion, not earnings or a regulatory approval. Interpretation: brand marketing is not evidence of improved profits. The current issuer event calendar separately verifies the Q3 call October29 at09:00ET; exact results-release clock time unverified.

Source dated 2026-10-09

Checked 2026-10-15T05:34:44.460Z.

Maya · Wall Street view

Reported rating changes: last 7 days — 0 upgrades / 0 downgrades; last 30 days — 0 upgrades / 0 downgrades. Partial coverage: counts are only the events found, not market-wide totals.

Covered analyst consensus: 4 Buy / 2 Hold / 2 Sell (8 ratings), as of 2026-10-15. Displayed public covered-analyst snapshot checked October15; Strong Buy grouped with Buy. Partial, cache-dependent census. Source.

Target changes in 30 days: 0 raises / 0 cuts (separate from rating changes). Selected visible attributed actions from rolling30-day window; bounded public table and cache coverage are incomplete. Zero counts mean none found here, not market-wide zeros. Targets are opinions, not measured returns. Checked 2026-10-15T05:34:44.460Z. Analyst opinion is context, not a trade trigger.

AMGN Amgen Inc ↑Healthcare · Drug Manufacturers - General

TECHNICAL SETUP

Symmetrical triangle · Bullish price pattern · Last close $426.32

Why bullish: The symmetrical triangle has broken upward on a completed candle, favouring a possible continuation higher. The closing price is above its 50-bar average ($402.24) and above its 200-bar average ($384.24).

What could go wrong: Breakout volume supports the move. A move below $396.01 would undermine this pattern.

TTM Squeeze · 4H: Squeeze is off; no release observed in the available calculation window. Momentum is bullish and rising (7.38). Momentum direction agrees with this setup. No fresh directional squeeze trigger.

360424489554Target $538.84Breakout $418.42Stop $396.01RSI (14)7030MACD (12, 26, 9)0MACDSignalTTM squeeze / momentum0Amber dots: compression · grey: off · last 20 bars28 Aug14 Oct
4H completed candles · EODHD · RSI 14 · MACD 12/26/9 · TTM 20. Dashed purple lines join matching price/indicator pivots; reference levels are not orders
Open interactive chart →
Breakout reference$418.42Stop reference$396.01Target reference$538.84Reward / risk at close3.7 : 1

Sam: technical risk review. See the dated company coverage and Sam’s decisions below for event checks and sizing; executable spreads are not verified.

Wave alternatives, company news & analyst evidence

Elliott-wave scenario · 4H

Leading count · 4H0123? · $428.2309-16 → 10-14 · Close $426.32
Grey: price closes. Colour: proposed count. Dashed: target scenario; timing is illustrative. Provisional.

Leading reading: Bullish contracting diagonal · developing · Wave 3. Potential Wave 3 target $428.23 (0.4% from the reported close). Wave trigger $426.59; count invalidation $374.46. Provisional: parent-degree/subdivision or other method checks remain unresolved; not a confirmed wave count.

Alternative count · 4H0123? · $480.3609-16 → 10-14 · Close $426.32
Grey: price closes. Colour: proposed count. Dashed: target scenario; timing is illustrative. Provisional.

Competing reading: Bullish expanding diagonal · developing · Wave 3. Potential Wave 3 target $480.36 (12.7% from the reported close). Wave trigger $426.59; count invalidation $374.46. Provisional: parent-degree/subdivision or other method checks remain unresolved; not a confirmed wave count.

Wave projections and classical-pattern targets are separate scenarios, not interchangeable take-profit orders. The interactive chart may use newer candles or different session grouping.

Maya · Company news

Older background. Older background: Amgen reported positive topline Phase3 OASIZ301 results for dazodalibep in systemic Sjögren’s disease. Interpretation: supportive clinical research, not approval or realized sales. The checked issuer archive still exposes September22 as newest; fresh news and next earnings timing remain incomplete.

Source dated 2026-09-22

No fresh material item identified in the checked coverage. No newer material item identified in this bounded accessible issuer/archive/search review; dynamic archive coverage and exact earnings timing remain incomplete. This is not proof of no news. Newsroom checked.

Checked 2026-10-15T05:34:44.460Z.

Maya · Wall Street view

Reported rating changes: last 7 days — 0 upgrades / 0 downgrades; last 30 days — 0 upgrades / 0 downgrades. Partial coverage: counts are only the events found, not market-wide totals.

Covered analyst consensus: 8 Buy / 12 Hold / 2 Sell (22 ratings), as of 2026-10-15. Displayed public covered-analyst snapshot checked October15; Strong Buy grouped with Buy. Partial, cache-dependent census. Source.

  • 2026-10-13 · Guggenheim: target cut · target USD 388 → 378. Source
  • 2026-10-12 · BMO Capital: target cut · target USD 450 → 415. Source
  • 2026-10-12 · Wells Fargo: target cut · target USD 435 → 430. Source

Target changes in 30 days: 5 raises / 4 cuts (separate from rating changes). Selected visible attributed actions from rolling30-day window; bounded public table and cache coverage are incomplete. Zero counts mean none found here, not market-wide zeros. Targets are opinions, not measured returns. Checked 2026-10-15T05:34:44.460Z. Analyst opinion is context, not a trade trigger.

DASH DoorDash, Inc. Class A Common Stock ↓Consumer Cyclical · Internet Retail

TECHNICAL SETUP

Symmetrical triangle · Bearish price pattern · Last close $183.92

Why bearish: The symmetrical triangle has broken downward on a completed candle, favouring a possible continuation lower. The closing price is below its 50-bar average ($191.77) and below its 200-bar average ($191.16).

What could go wrong: Breakout volume supports the move. A move above $197.91 would undermine this pattern.

TTM Squeeze · 4H: Squeeze is off; no release observed in the available calculation window. Momentum is bullish and falling (2.61). Momentum direction conflicts with this setup. No fresh directional squeeze trigger.

144178212246Stop $197.91Breakout $193.53Target $151.70RSI (14)7030MACD (12, 26, 9)0MACDSignalTTM squeeze / momentum0Amber dots: compression · grey: off · last 20 bars28 Aug14 Oct
4H completed candles · EODHD · RSI 14 · MACD 12/26/9 · TTM 20. Dashed purple lines join matching price/indicator pivots; reference levels are not orders
Open interactive chart →
Breakout reference$193.53Stop reference$197.91Target reference$151.70Reward / risk at close2.3 : 1

Sam: technical risk review. See the dated company coverage and Sam’s decisions below for event checks and sizing; executable spreads are not verified. Short availability and borrowing costs unverified.

Wave alternatives, company news & analyst evidence

Elliott-wave scenario · 4H

Leading count · 4H0123? · $277.8907-23 → 10-14 · Close $183.92
Grey: price closes. Colour: proposed count. Dashed: target scenario; timing is illustrative. Provisional.

Leading reading: Bullish impulse · developing · Wave 3. Potential Wave 3 target $277.89 (51.1% from the reported close). Wave trigger $238.83; count invalidation $166.58. Provisional: parent-degree/subdivision or other method checks remain unresolved; not a confirmed wave count.

Alternative count · 4H01207-23 → 10-14 · Close $183.92
Grey: price closes. Colour: proposed count. Provisional.

Competing reading: Bullish contracting diagonal · developing · Wave 3. No usable projected target supplied for this reading. Wave trigger $238.83; count invalidation $166.58. Provisional: parent-degree/subdivision or other method checks remain unresolved; not a confirmed wave count.

Wave projections and classical-pattern targets are separate scenarios, not interchangeable take-profit orders. The interactive chart may use newer candles or different session grouping.

Maya · Company news

Scheduled event. Scheduled event: DoorDash announced November4 Q3 results after the US close, followed by a separate16:30ET call. This is a calendar announcement, not an operating result or verified overnight release. Positive analyst opinions conflict with the bearish setup; no borrow or short execution is established by news.

Source dated 2026-10-09

Checked 2026-10-15T05:34:44.460Z.

Maya · Wall Street view

Reported rating changes: last 7 days — 0 upgrades / 0 downgrades; last 30 days — 0 upgrades / 0 downgrades. Partial coverage: counts are only the events found, not market-wide totals.

Covered analyst consensus: 23 Buy / 6 Hold / 0 Sell (29 ratings), as of 2026-10-15. Displayed public covered-analyst snapshot checked October15; Strong Buy grouped with Buy. Partial, cache-dependent census. Source.

  • 2026-10-14 · Guggenheim: reiteration. Source
  • 2026-10-12 · Cantor Fitzgerald: target cut · target USD 260 → 240. Source
  • 2026-10-05 · Wells Fargo: target raise · target USD 225 → 230. Source

Target changes in 30 days: 1 raises / 1 cuts (separate from rating changes). Selected visible attributed actions from rolling30-day window; bounded public table and cache coverage are incomplete. Zero counts mean none found here, not market-wide zeros. Targets are opinions, not measured returns. Checked 2026-10-15T05:34:44.460Z. Analyst opinion is context, not a trade trigger.

Pattern targets are conditional measurements. Elliott alternatives remain unqualified; full analysis is linked below. Sam’s rules-based checklist is not an independent AI approval. Gaps can exceed stops.

TTM Squeeze settings and interpretation

20-bar Bollinger bands (2 population standard deviations); original Keltner: SMA20 typical price ± 1.5 × SMA20 high-low range; 20-bar regression momentum. Latest completed 4H candles only; a fresh trigger requires a release on the latest candle with positive/rising or negative/falling momentum. Other platforms may use different Keltner settings. Method reference.

Maya’s company & AI news

Energy lifts consumer inflation

2026-10-14 · Released official data ·08:30ET

September CPI rose0.6% month-on-month and3.7% year-on-year; core rose0.3% and2.6%. Gasoline increased9.1%, accounting for over half the monthly headline increase. Interpretation: inflation and funding-cost sensitivity remain material. Pre-release consensus is unavailable here, so no surprise claim or attribution of the closing selloff is made. Today’s PPI and retail sales remain scheduled. Source →

Growth pockets, price pressure

2026-10-14 · Released Fed contact report

The Beige Book described growth in nine districts and little change in three. Most consumer spending changed little; prices rose robustly in three districts, moderately in eight and modestly in one. Interpretation: manufacturing strength and consumer caution coexist. Evidence was collected through October5 from qualitative, nonrandom contacts; it is not a national growth statistic or Fed officials’ policy view. Source →

Gilead adds oncology research

Healthcare · Drug Manufacturers - General

2026-10-14 · Date-only company agreement

Gilead Sciences Inc (GILD, Healthcare) gained exclusive development/commercialization rights in a three-candidate solid-tumor collaboration with Vir. Upfront consideration is$90m, including$25m equity. Interpretation: broader research potential with clinical risk; milestones are conditional, not product revenue. Publication time unverified; no overnight label. Source →

Fastenal growth with tradeoffs

Industrials · Industrial Distribution

2026-10-14 · Released company results

Fastenal Company (FAST, Industrials) reported sales$2.4633bn (+15.5%) and EPS$0.35. Gross margin declined to44.8% from45.3%; its annual device-signing goal was reduced. Interpretation: sales and operating leverage strength face mix and execution risks. No consensus surprise or causal price claim. A six-signal daily ranking does not establish a completed4H entry. Source →

Social attention · saved history

Rolling 24-hour mention snapshots; dates and times below are UTC. Windows may overlap. Missing history is unknown, not zero. This is attention, not sentiment or a trading signal.

CompanyCurrentPrior observations / follow-up
CoreWeave, Inc. Class A Common Stock (CRWV)
Technology
177
10-15 05:33 UTC
10-07 05:37 UTC: 5
Higher versus 2026-10-07: +172 mentions. History limited: only two comparable saved observations.
Build a longer comparable history; check the next saved snapshot for persistence.
Unknown: 10-02 (not saved), 10-06 (not saved), 10-08 (not saved), 10-09 (not saved), 10-10 (not saved), 10-12 (not saved), 10-13 (not saved), 10-14 (not saved).
Micron Technology Inc (MU)
Technology
367
10-15 05:33 UTC
10-06 19:24 UTC: 192
10-07 05:37 UTC: 252
10-08 05:37 UTC: 385
10-10 05:32 UTC: 231
10-13 06:24 UTC: 324
Mixed sequence: 6 observations, 2026-10-06 to 2026-10-15. Overall 192 → 367 (+175 mentions). Irregular rolling snapshots, not a continuous daily trend.
Check whether attention persists at the next snapshot and whether audited price confirms it. Attention alone is not a trade signal.
Unknown: 10-09 (not saved), 10-12 (not saved), 10-14 (not saved).
Nebius Group N.V. (NBIS)
Communication Services
158
10-15 05:33 UTC
10-09 05:32 UTC: 47
10-13 06:24 UTC: 41
Mixed sequence: 3 observations, 2026-10-09 to 2026-10-15. Overall 47 → 158 (+111 mentions). Irregular rolling snapshots, not a continuous daily trend.
Build a longer comparable history; check the next saved snapshot for persistence.
Unknown: 10-02 (not saved), 10-06 (not saved), 10-07 (not saved), 10-08 (not saved), 10-10 (not saved), 10-12 (not saved), 10-14 (not saved).
NVIDIA Corporation (NVDA)
Technology
125
10-15 05:33 UTC
10-06 19:24 UTC: 127
10-07 05:37 UTC: 159
10-12 06:29 UTC: 37
Mixed sequence: 4 observations, 2026-10-06 to 2026-10-15. Overall 127 → 125 (-2 mentions). Irregular rolling snapshots, not a continuous daily trend.
Check whether attention persists at the next snapshot and whether audited price confirms it. Attention alone is not a trade signal.
Unknown: 10-02 (not saved), 10-08 (not saved), 10-09 (not saved), 10-10 (not saved), 10-13 (not saved), 10-14 (not saved).
Rocket Lab USA Inc. (RKLB)
Industrials
98
10-15 05:33 UTC
10-02 05:38 UTC: 35
Higher versus 2026-10-02: +63 mentions. History limited: only two comparable saved observations.
Build a longer comparable history; check the next saved snapshot for persistence.
Unknown: 10-06 (not saved), 10-07 (not saved), 10-08 (not saved), 10-09 (not saved), 10-10 (not saved), 10-12 (not saved), 10-13 (not saved), 10-14 (not saved).
Advanced Micro Devices Inc (AMD)
Technology
77
10-15 05:33 UTC
10-02 05:38 UTC: 31
10-06 19:24 UTC: 115
10-07 05:37 UTC: 164
Mixed sequence: 4 observations, 2026-10-02 to 2026-10-15. Overall 31 → 77 (+46 mentions). Irregular rolling snapshots, not a continuous daily trend.
Check whether attention persists at the next snapshot and whether audited price confirms it. Attention alone is not a trade signal.
Unknown: 10-08 (not saved), 10-09 (not saved), 10-10 (not saved), 10-12 (not saved), 10-13 (not saved), 10-14 (not saved).
ASML Holding N.V. New York Registry Shares (ASML)
Technology
62
10-15 05:33 UTC
No saved prior count.
History limited: no comparable saved prior count.
Build a longer comparable history; check the next saved snapshot for persistence.
Unknown: 10-02 (not saved), 10-06 (not saved), 10-07 (not saved), 10-08 (not saved), 10-09 (not saved), 10-10 (not saved), 10-12 (not saved), 10-13 (not saved), 10-14 (not saved).
Apple Inc. (AAPL)
Technology
65
10-15 05:33 UTC
10-07 05:37 UTC: 35
10-10 05:32 UTC: 31
10-14 07:42 UTC: 28
Mixed sequence: 4 observations, 2026-10-07 to 2026-10-15. Overall 35 → 65 (+30 mentions). Irregular rolling snapshots, not a continuous daily trend.
Check whether attention persists at the next snapshot and whether audited price confirms it. Attention alone is not a trade signal.
Unknown: 10-02 (not saved), 10-06 (not saved), 10-08 (not saved), 10-09 (not saved), 10-12 (not saved), 10-13 (not saved).

Saved current24h values only; previous24h fields are not converted into dated observations. These are rolling 24-hour mention counts at actual retrieval times, may overlap and are not independent calendar-day totals. Missing saved counts and not-listed observations are unknown, never zero. Prior observations are the latest five available per current attention name; calendar gaps remain explicit. Public source: ApeWisdom stock-focused Reddit feed. Only saved observations from 2026-10-02, 2026-10-06, 2026-10-07, 2026-10-08, 2026-10-09, 2026-10-10, 2026-10-12, 2026-10-13, 2026-10-14, 2026-10-15 were checked.

Public attention map

Original public-source synthesis from dated issuer, SEC and attributed analyst evidence for the five sealed-scan featured names. This is not measured social sentiment. Social counts remain separately dated with coverage limits. Priority AI names remain internally reviewed and require an audited technical setup for reader radar inclusion. No private subscription evidence used. Checked 2026-10-15T05:36:36.638Z. Public research leads, not verified consensus or trade signals.

Biopharma: development potential and valuation

GILD — Gilead Sciences Inc · Healthcare; AMGN — Amgen Inc · Healthcare

Bull case: Gilead’s new oncology collaboration and Amgen’s older positive Phase3 result provide distinct pipeline arguments. Bear case: Development is uncertain; Amgen’s recent analyst target cuts and mixed ratings show disagreement. Fresh Amgen news and next earnings timing remain incomplete.

Catalyst: Gilead development milestones; Amgen full study/regulatory updates. No unverified next earnings date assumed. Alex: Parent-confirmed sealed scan: Gilead inverse head-and-shoulders long; Amgen ascending triangle long. Elliott qualification and risk decisions are documented separately.

Public source · 2026-10-14 · Public source · 2026-09-22 · Public source · 2026-10-13

Insurance and tobacco: price strength, different risks

MET — MetLife Inc · Financial Services; MO — Altria Group · Consumer Defensive

Bull case: MetLife’s September22 rating upgrade and Altria’s bullish price pattern offer separate constructive arguments. Bear case: MetLife analyst target cuts coexist with raises; Altria’s public consensus includes Sell ratings. Insurance risks and tobacco regulation/business decline cannot be inferred away from a chart.

Catalyst: MetLife November4 afterclose results and November5 09:00ET call; Altria October29 09:00ET call. Alex: Parent-confirmed sealed scan: MetLife inverse head-and-shoulders long; Altria bull flag long. Triggers and Elliott alternatives reviewed separately.

Public source · 2026-10-07 · Public source · 2026-10-15 (observed calendar; publication date unavailable) · Public source · 2026-09-22

Delivery: bearish setup versus positive Street view

DASH — DoorDash, Inc. Class A Common Stock · Consumer Cyclical

Bull case: Guggenheim reiterated Buy on October14 and the covered snapshot remains predominantly positive. Bear case: Cantor cut its target on October12 while the sealed scan identified a bearish descending triangle. Analyst opinion does not supply borrow evidence.

Catalyst: November4 afterclose results, separate16:30ET call. Alex: Parent-confirmed sealed scan: descending triangle short; research setup requires independent borrow/execution and risk checks before any model short.

Public source · 2026-10-09 · Public source · 2026-10-14

Model portfolio · corrected stop accounting

Since the 2026-10-02 cash launch, through 2026-10-14 US close; ETF comparisons use the frozen 2026-10-01 closing baseline. Simulation · zero model fees · price-only basis.

Portfolio value$99,526.07
Cash$68,387.79
Realised P&L-$1,612.21
Open P&L$1,138.28
Same-period comparisonReturnModel comparison
Model portfolioCash-inclusive change -$473.93-0.47%—
SPY · S&P 500 price proxy+0.73%1.21% behind SPY
QQQ · Nasdaq-100 price proxy-1.78%1.30% ahead of QQQ

Ahead/behind compares the displayed percentage returns by subtraction; it is not a relative-return ratio or risk-adjusted alpha.

Since prior report: -$279.14 (-0.28%).

Open holdings · 4

HoldingOpen P&LStop / target
Amazon.com Inc (AMZN)Consumer Cyclicallong · 19.6796 shares · cost $254.07 · close $254.16$1.77$244.73
$320.68
Duke Energy Corporation (DUK)Utilitieslong · 43.1406 shares · cost $115.90 · close $119.66$162.21$113.29
$127.26
Accenture plc (ACN)Technologylong · 50.5740 shares · cost $197.73 · close $215.01$873.92$192.58
$219.03
Hilton Worldwide Holdings Inc (HLT)Consumer Cyclicallong · 30.7920 shares · cost $324.76 · close $328.02$100.38$318.95
$342.99Updated 2026-10-12T13:30:00Z

Closed trades · 4

PositionExit date / priceRealised P&L
Astera Labs, Inc. (ALAB)Technology2026-10-09
$342.00
-$459.37
Advanced Micro Devices Inc (AMD)Technology2026-10-12
$596.07
-$302.04
NVIDIA Corporation (NVDA)Technology2026-10-12
$227.02
-$448.09
Generac Holdings Inc (GNRC)Industrials2026-10-14
$201.95
-$402.70

Closed positions leave open exposure and running P&L; their realised losses remain in cash and performance. Approved model stops use the stop price on audited touch, or first audited opening price on an adverse gap. A touch proves a candle window, not an exact instant or broker execution. Targets and discretionary exits retain separate execution conventions.

Exposure, accounting basis and limitations

Long exposure $31,138.28; short exposure -$0.00; net exposure $31,138.28; cash $68,387.79 includes any restricted short proceeds and is not buying power.

Price performance only; no dividends or cash interest. Recorded transaction and borrow charges deducted; pending borrow charges must be reconciled. Before taxes. Benchmark ETF proxies, not official index total returns. Insufficient history; excess return is not risk-adjusted alpha. One unit = $5,000.00; maximum 3 units and 15% per name at entry; combined shorts capped at 30%. Gaps may exceed planned stop risk. Dated level revisions take effect prospectively, with original levels retained.

Since inception · portfolio versus SPY and QQQ

Same measurement period: 2026-10-01 close to 2026-10-14 close. The model launched with $100,000 cash on 2 October; its first trading day was 2 October.

Portfolio / benchmarkReturn over the periodBasis
Wave Workshop simulated portfolio-0.47%Cash-inclusive equity; price-only; zero model fees
SPY · S&P 500 ETF+0.73%Adjusted daily prices · 763.99 → 769.60
QQQ · Nasdaq-100 ETF-1.76%Adjusted daily prices · 742.03 → 728.95

Contextual comparison: ETF daily prices include the provider’s split/dividend adjustments; the simulated portfolio excludes dividends and cash interest. These are ETF proxies, not official index total returns. The original benchmark baseline is preserved. This separate adjusted daily comparison does not replace frozen-baseline accounting.

Corrected performance history · original figures retained for audit

On 15 October Jean-Marc approved applying the stop-touch/adverse-opening-gap convention to existing stopped positions and requested a recalculation. Earlier published values were not based on this completed exit convention. Entries and selections are unchanged; closed losses are retained. Available dated report observations are restated below; missing observations are not fabricated.

Report / price dateCorrected equityDaily P&LSince inceptionSPY / QQQ since inception
2026-10-02 / 2026-10-01$100,000.00Unavailable+0.00%+0.00% / +0.00%
2026-10-06 / 2026-10-05$100,000.00$0.00+0.00%+1.43% / +1.90%
2026-10-07 / 2026-10-06$100,000.00$0.00+0.00%+1.98% / +2.37%
2026-10-08 / 2026-10-07$100,289.14$289.14+0.29%+1.72% / +2.11%
2026-10-09 / 2026-10-08$99,895.21-$393.92-0.10%+1.29% / +0.75%
2026-10-10 / 2026-10-09$99,923.07$27.85-0.08%Unavailable / Unavailable
2026-10-12 / 2026-10-09$99,923.07$0.00-0.08%+1.90% / +1.24%
2026-10-13 / 2026-10-12$99,898.79-$24.27-0.10%Unavailable / Unavailable
2026-10-14 / 2026-10-13$99,805.21-$93.58-0.19%+1.84% / +0.21%
2026-10-15 / 2026-10-14$99,526.07-$279.14-0.47%+0.73% / -1.78%

Restatement evidence and original-versus-corrected values

Full dated accounting and source evidence

Sam’s open-holdings review

Corrected after the 15 October stop-rule approval; closed positions appear in realised history above. No real orders.

HoldingDecisionReason
Amazon.com Inc (AMZN) · Consumer CyclicalRetainRetain one unit under existing levels: 254.16 still exceeds original 251.87 trigger and 244.725 stop. Bearish MACD and RSI 47.92 are adverse evidence; a completed failure of support prompts renewed exit review. No addition: Consumer Cyclical already has two recorded names.
Duke Energy Corporation (DUK) · UtilitiesRetainRetain one unit under the existing 113.29 stop and 127.26035 target. Completed 119.66 close and bullish MACD support continuation; RSI 75.66 is extended and PPI/rates-sensitive repricing is a competing risk. No increased size.
Accenture plc (ACN) · TechnologyRetainRetain two units under original 192.584793 stop and 219.034957 target. Completed 215.01 close and bullish MACD support the case; RSI 69.87 and proximity to target limit new conviction. No retrospective extension or Technology addition.
Hilton Worldwide Holdings Inc (HLT) · Consumer CyclicalRetainRetain two units with the 12 October effective 318.950012 stop and original 342.988541 target. Completed 328.02 close remains above protection with bullish MACD. Consumer growth and rates are shared risks; no additional sector name.

No stopped positions remain as pending exits.

The remaining Amazon and Accenture positions share growth/cloud exposure; Duke Energy adds rate-sensitive utilities and Hilton adds consumer/travel exposure. Targa remains a conditional Energy selection, not a holding. No numerical correlation estimate is asserted. Selective phase after the first 50% gross exposure threshold. Fixed USD5000 units; max three units/15% equity per name and 30% combined shorts. No experimental risk budgets or exit mechanics activated.

Sam’s portfolio decisions

Decision snapshot: 15 October at 07:03 BST. Prices through 2026-10-14 US close. Simulation only.

New selection

Targa Resources Inc (TRGP)Energy · Oil & Gas Midstream

Selected · awaiting audited opening

Select one fresh Targa Resources unit for the 15 October opening only within 290.84–293.00. Prior-session close: $291.11.

Planned allocation
1 unit · $5,000.00
Intended opening
15 October at 14:30 BST
Opening price must be
$290.84–$293.00
Completed 4H trigger
$290.84
Stop reference
$278.16
Target reference
$344.59
Planned entry-to-stop distance
$253.24 · gaps may exceed this

Key caution: Yesterday's opening gap above the prior range reversed; the latest close is only just above the triangle trigger.

This is a conditional simulated selection. No purchase has been recorded; an opening outside the range does not qualify. Zero model fees; no real order.

Original selection record · portfolio figures superseded by stop restatement

Original decision and size are preserved. Use the corrected portfolio and capacity figures in this edition; earlier exposure/cash statements below predate the approved stop correction.

Select one fresh Targa Resources unit for the 15 October opening only within 290.84–293.00.

The completed 14 October 4H close of 291.109985 remains above the 290.837216 ascending-triangle trigger, with bullish MACD and RSI57.92.

Daily price is above rising50/100/200-day averages and the last completed weekly close is above10/40-week averages.

Retain structural stop278.160003 and measured triangle target344.586843; minimum reward/risk at the maximum opening is3.48.

XLE now has matching14 October daily/4H evidence and +3.935 percentage-point20-session relativeSPY return; its ordinary momentum reading supports context, not the stock trigger.

Yesterday’s296.53 daily opening exceeded the old295cap, then price reversed toward support: that failed gap and nearby294.22–296.63 resistance, unconfirmed triangle volume, and the shorter double-bottom target304.19 limit conviction to one unit.

The prior Oct14 entry remains unfilled; this is a separate actual-time Oct15 decision.

Earnings are verified for November5before open; today’s12:30UTC PPI/retail-sales/claims releases precede entry, so enforce opening conditions and reassess material new evidence.

No real order.

Prospective capacity using USD98,450.87 equity: one USD5,000 fill would create one Energy holding at5.079% gross exposure and USD253.24 original-stop distance (0.257% of equity), within the two-name/25% gross/1.5% sector stop-risk limits.

Aggregate original-entry-to-stop distances would total USD2,690.67; cash would be USD40,000 and gross exposure59.37% if filled.

Technology additions remain frozen with four names at29.13% gross exposure; unfilled exits release no capacity.

These are reference distances; gaps can exceed stops.

No fill has been booked.

Portfolio impact · conditional on a fill

Cash now
$68,387.79
Cash if selected entry fills
$63,387.79
Gross exposure now / if filled
31.29% / 36.31%
Original entry-to-stop distances · now / if filled
$825.22 / $1,078.46

Recorded stop closures have released their proceeds and are excluded from current exposure. Stop distances are reference amounts; gaps can produce larger losses.

Technical setups not selected for the portfolio

These chart setups did not qualify for a new simulated entry at this review.

CompanyWhy not selected
Amgen Inc (AMGN)Healthcare · Drug Manufacturers - GeneralNot selected: strong fresh triangle and daily trend, but current issuer archive endsSeptember22 and next earnings timing remains unverified; this essential issuer-event check is unresolved, not an adverse earnings forecast.
DoorDash, Inc. Class A Common Stock (DASH)Consumer Cyclical · Internet RetailNot selected: audited borrow availability, borrowing cost, margin and dividend obligations are unavailable.
Gilead Sciences Inc (GILD)Healthcare · Drug Manufacturers - GeneralNot selected: current measured reward/risk is below Sam’s 1.5 preference; no target enlargement or backfilled trigger.
MetLife Inc (MET)Financial Services · Insurance - LifeNot selected: current measured reward/risk is below Sam’s 1.5 preference; no target enlargement or backfilled trigger.
Altria Group (MO)Consumer Defensive · TobaccoNot selected after sizing comparison: valid fresh flag, but4HRSI76.88/dailyRSI72.06 and daily price7.9%aboveSMA50 show an extended entry. Prefer one less extended Targa starter; do not alter the measured flag target.
Simulation entry and exit conventions

Sam selects 1–3 fixed $5,000 units within the existing exposure limits. A completed 4H trigger must precede selection; entries use the next independently audited US opening within the stated range. Fractional shares and zero model fees apply. Historical entries are shown in the portfolio above, not repeated as new decisions here.

Model stops now close at the audited touch/stop price or adverse audited opening gap, with zero fees. Closed losses stay in realised history. Any continued exposure requires a new prospective selection; no retrospective stop extension. Other exit conventions remain separately governed.